8/2/2011 12:17 PM ET|
5 big names ripe for takeover
Despite a hard economy, it looks as if the market’s corporate raiders are getting back to work. Here’s why names like Whirlpool, SkyWest and Aetna could be takeover targets -- and how to profit if they are.
You don't need a rip-roaring economy to bring out the market's raiders and barbarians.
Wall Street's takeover artists typically thrive during booming economies and bull markets -- perhaps most famously during the late 1980s, when they knocked at the gates of high-profile companies like RJR Nabisco in notorious takeover battles.
But despite anemic economic growth, conditions right now could be leading us into another wave of leveraged buyouts, the experts say.
These buyouts specialists have tons of cash on hand, and money is cheap now anyway. And many solid public companies are suffering with weak profits and fallen stock prices.
In fact, any number of household names could have targets on their backs -- including, according to a recent Deutsche Bank report, Whirlpool (WHR, news), SkyWest (SKYW, news), Xerox (XRX, news), Tyson Foods (TSN, news) and Aetna (AET, news).
"We think conditions are very supportive of an up-cycle in LBOs," says Binky Chadha, co-author of that report, "On the Cusp of Another LBO Upcycle."
In fact, a new round of takeover fever may have already begun. Worldwide, takeovers by private equity shops averaged 725 per quarter in 2009. This rose to 942 per quarter last year and hit a pace of 1,024 per quarter during the first half of this year, according to Thomson Reuters.
How to profit from takeovers
The big money in LBOs, of course, is made by the artists who buy businesses and then take them private, using large amounts of leverage, or debt -- often borrowed against the assets of the target company.
In private hands, companies can get a makeover as managers implement strategic plans that gradually improve business, often slashing costs, cutting jobs and selling assets in the process. "They're not caught in the quarterly earnings treadmill," says Andrew Corn, the chief investment officer of E5A Funds. "That allows managers to cut costs, figure out where companies are profitable and start to drive revenue again."
When they're done, raiders typically spin out the company to the public again, collecting hefty profits and fees -- usually 20% of any upside. "Everyone makes a ton of money when they sell the company or go public again. That's where the big payday is," says Corn.
On example: Blackstone Group (BX, news) recently took Kosmos Energy (KOS, news) public in an initial public offering at a value that was six times what it originally paid for the company, says Blackstone.
But average investors can make money here as well if they can spot targets early on -- before news of a takeover try surfaces. Such news can juice stocks nicely.
Shares of Clorox (CLX, news), for example, moved to $75 in July from lows of $67 that month, on news that shareholder activist Carl Icahn was offering $80 a share, a bid the Clorox board rejected. By the way, I've noticed that Icahn has also built big positions in Hain Celestial (HAIN, news) and Oshkosh (OSK, news), suggesting something's going on at those two as well.
And shares of 99 Cents Only Stores (NDN, news) moved up sharply to almost $20 from below $17 in March when the discount chain announced it had received a buyout offer from its founding family and an investment firm to take the company private. Late last year, shares of J. Crew and Jo-Ann Stores also jumped nicely on news they were being bought out.
The big money in LBOs
There are several reasons to believe the time is right for more takeover activity:
- Private equity funds have "extraordinary amounts of dry powder," says Deutsche Bank. They have $500 billion in unused capital, which works out to $1.5 trillion in purchasing power when you add in the potential leverage on those funds. "Private equity funds are loaded with cash, and they don't get paid to sit on cash," says Timothy Ghriskey, the chief investment officer at Solaris Group, which manages $2 billion. "We invest in private equity for clients, and we don't want funds sitting on cash because it makes us wonder, 'What are we paying them for?'"
- Money is cheap. Interest rates and yields on corporate debt are extremely low. This means takeover artists can readily borrow more to leverage deals.
- Many stocks are also cheap, despite strong underlying fundamentals like solid free cash flow and relatively good earnings growth. This makes them attractive targets -- especially when they have some fixable defect like below-average profit margins, and a brand name with continuing value.
But the hard part is finding the actual targets before the rest of the market catches on.
VIDEO ON MSN MONEY
Corporate lobbyists have purchased the votes of our lawmakers at all levels of government. Joe Sixpack is downtrodden by the abominable and blatant greed of the powers that be. Those dogs care not a wit for us or our progeny or elders beyond how we can increase productivity and profit for their benefit, or be seduced into keeping them in public office - only to advance private interests while ignoring our concerns.
How much longer are we willing to put up with it, people? Can we change the status quo -- or is it too late?
Copyright © 2014 Microsoft. All rights reserved.
Fundamental company data and historical chart data provided by Morningstar Inc. Real-time index quotes and delayed quotes supplied by Morningstar Inc. Quotes delayed by up to 15 minutes, except where indicated otherwise. Fund summary, fund performance and dividend data provided by Morningstar Inc. Analyst recommendations provided by Zacks Investment Research. StockScouter data provided by Verus Analytics. IPO data provided by Hoover's Inc. Index membership data provided by Morningstar Inc.
[BRIEFING.COM] The major averages remain near their early lows with the Nasdaq (-0.6%) seeing the largest decline.
The index lags amid weakness in technology (-0.6%) and biotech. The iShares Nasdaq Biotechnology ETF (IBB 257.50, -1.43) trades lower by 0.5%. Similar to the biotech ETF, the health care sector holds a loss of 0.5%.
With stocks on the defensive, traditional safe-haven assets remain in demand. Gold futures trade up 1.5% at $1366.60/ozt while Treasuries sit ... More
More Market News
|There’s a problem getting this information right now. Please try again later.|